about
Cytomegalovirus and cancer of the prostate: in vitro transformation of human cellsL-Asparaginase: discovery and development as a tumor-inhibitory agentcis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of miceInhibitory effect of hydroxynitrodihydrothymine on the growth of Ehrlich ascites tumor cellsStability and preliminary pharmacokinetic studies of 1-(2-chloroethyl)-3-[1-(5'-paranitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea (RFCNU), a nonimmunosuppressive nitrosoureaRaynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinomaRaynaud's phenomenon after vinblastine-bleomycin chemotherapyLong-term treatment with cis-dichlorodiammineplatinum(II)-vinblastine-bleomycin: possible association with severe coronary artery diseaseAnimal models for the comparative assessment of neurotoxicity following repeated administration of vinca alkaloidsExperimental animal models of adriamycin cardiotoxicityPhase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group studyAntineoplastic effect of orally administered 1-alkyl carbamoyl derivatives of 5-fluorouracil on sc implanted Lewis lung carcinoma and B16 melanomaVincristine (NSC-67574) in the treatment of small-cell anaplastic carcinoma of the lungCCNU nephrotoxicity following sustained remission in oat cell carcinomaUnusual neuromuscular toxicity after treatment of bone sarcomas with adriamycin, vincristine, and cyclophosphamideCombination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II studyReduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamstersAdriamycin and mitomycin C: possible synergistic cardiotoxicityCytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poisonBiologic activity of MCNU: a new antitumor agentcis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancerPotential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards areaAcute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dog1-year followup of cardiac status after adriamycin therapyQuantitative experimental evaluation of adriamycin cardiotoxicity in the mouseTamoxifen and estrogen hypercalcemiaStudies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicityNoninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval)Changes in amino acid metabolism caused by 6-azauridine triacetate: relevance to cancer treatmentCentral nervous system disturbances after combined administration of procarbazine and mechlorethamineHigh incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapyTamoxifen retinopathyAtaxia and athetosis as side effects of chemotherapy with vincristine in non-Hodgkin's lymphomaAcute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapiesInvasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsyAnthracycline cardiomyopathy monitored by morphologic changesNoninvasive profile in the prospective monitoring of adriamycin cardiomyopathyAdriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10Serial studies of cardiac function in patients receiving adriamycinQRS voltage change with adriamycin administration
P1433
Q28275361-8AC582F1-DA0A-4BB9-8E2A-B2DDEF72232CQ28277734-5EC44136-68BD-4A49-A78E-0974F9C16C37Q28284338-A11ED488-A7C8-4EBE-88A5-B050B9AE2F92Q28317015-C7DAACAE-FCBF-43FD-8158-88A3D21BBD75Q28317451-E9AAEEFD-CF37-46D3-BF1A-D80366F11E0FQ28318155-F5F520B9-A79C-4B02-8841-E92575085C60Q28318284-2BCE4B4D-337A-403A-AFF6-CC952D9DE2DAQ28318500-E0A58C93-F93D-47AA-99E6-9D73F6C7EE01Q28318939-ADAFBD26-4E1E-4845-BB7F-87E268387BE6Q28319051-5ABE9964-5BC7-4193-B98E-2BE2A884F740Q28319128-7FD9AEA5-8A09-41D8-94F4-006456E47B2CQ28319289-492F97C3-AC3E-4878-95DA-FE2A4BBD55F6Q28320596-2677A8E7-9EBE-4FA0-9620-AAC2A2A2ED86Q28322484-68AFCD72-934D-4B54-82EC-CE1728BC2E40Q28323716-7B086310-2AAE-40DE-B52B-2082DCEB42CDQ28325085-4A03CAA4-C357-4491-802C-66570769E1D2Q28325654-A2F429F3-570C-40D3-8697-0E6F9433802EQ28326957-13448C08-8432-4AF8-AB1C-3686DB1DC400Q28326965-659DC0F4-C882-4BD1-8A09-4F8F574FBD2FQ28327536-FE643944-90B7-417F-B18E-6EE9E4B7A250Q28328656-E30A8B2D-E77F-4696-AD58-983E2E10CCBEQ28328658-C87ABE81-D835-4D14-985B-586E663349D4Q28328885-228BC577-A5D6-43E2-A9F7-734724C7E239Q28328887-2BE46E52-A980-4D93-9BA1-A8138000ED1EQ28328892-5028C292-D621-476F-964D-D6B209A3FEB2Q28328895-DAFD0776-E759-49BE-AF58-84A07731E972Q28329409-322AE107-37BF-4F1B-BA50-5F0D844545C9Q28329434-420CDF45-25F0-4A34-9CBF-FFFAE97476C0Q28330671-68FF91EC-CC24-4C25-92C0-D6CB99A36106Q28330992-C1418E6C-059C-45E4-B32A-E59660FBEAA0Q28330995-D67EA1C7-872D-4976-8302-09AE51D3D97EQ28332246-A5ED4432-0C41-49FE-BA6A-18F901C9C052Q28332448-2E32FA7A-B8E2-4A69-813D-651EC5A99B7EQ28332452-6A72B2DF-896C-4C10-8D42-BE266B27303BQ28332781-DDBE6EBA-EA8D-44A4-BC70-0E889030F80CQ28332787-90CD64B6-653F-4B80-BFB5-F02962C4BEFDQ28332789-54CAC62B-81FB-4133-B8B0-F6990A2DE1CAQ28332793-5BD5F530-1B26-4F79-BFFD-CD78AFC057D1Q28332796-806CF466-2012-4D12-8F7C-6C83CCC9A3D9Q28332800-177E7E20-A44F-412B-AFB1-992EE5D67C35
P1433
description
czasopismo naukowe
@pl
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
scientific journal
@en
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
науковий журнал
@uk
name
Cancer Treatment Reports
@ast
Cancer Treatment Reports
@de
Cancer Treatment Reports
@en
Cancer Treatment Reports
@es
Cancer Treatment Reports
@fr
Cancer Treatment Reports
@it
Cancer treatment reports
@nl
type
label
Cancer Treatment Reports
@ast
Cancer Treatment Reports
@de
Cancer Treatment Reports
@en
Cancer Treatment Reports
@es
Cancer Treatment Reports
@fr
Cancer Treatment Reports
@it
Cancer treatment reports
@nl
altLabel
Cancer Treat Rep
@en
Cancer Treat. Rep.
@en
prefLabel
Cancer Treatment Reports
@ast
Cancer Treatment Reports
@de
Cancer Treatment Reports
@en
Cancer Treatment Reports
@es
Cancer Treatment Reports
@fr
Cancer Treatment Reports
@it
Cancer treatment reports
@nl
P1055
P1156
P1476
Cancer Treatment Reports
@en